DexCom, Inc. (DXCM) Financials
Key financial figures for DexCom, Inc. (Q3 2026).
DexCom Q3 2026 revenue rose 11% to $1.344B with GAAP operating margin of 24.3%, and the company raised the low end of 2026 revenue guidance to $5.20-$5.25B. Revenue: $1.344B, up 11% year-over-year on a reported and an organic basis (Q3 2025: $1.209B). U.S. revenue was $969.8M (+14%) and international revenue was $374.7M (+5% reported and organic). Margins: GAAP gross margin was 64.3% (60.5% a year earlier) and GAAP operating income was $327.2M, or 24.3% of revenue, up 420 basis points year-over-year. Non-GAAP operating income was $339.5M (25.3% of revenue) and adjusted EBITDA was $435.2M (Q3 2025: $368.4M). On the outlook: Full-year 2026: revenue of $5.20-$5.25 billion (approximately 12-13% growth; previously $5.18-$5.25 billion), non-GAAP gross profit margin of approximately 64% (reiterated), non-GAAP operating margin of approximately 24% (previously 23.5-24%), and adjusted EBITDA margin of approximately 32% (previously 31.5-32%). Figures are for Q3 2026, as DexCom, Inc. reported them.
- Revenue
- $1.3B
- Net Income
- $275M
- EPS
- $0.73
- Total Assets
- $6.2B
- Operating Cash Flow
- $326M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $1.3B | $275M | $0.72 | 24.34% | $273M |
| Q2 FY2026 | $1.3B | $249M | $0.64 | 24.33% | $185M |
| Q1 FY2026 | $1.2B | $200M | $0.51 | 21.42% | $449M |
| Q4 FY2025 | $1.3B | $267M | $0.68 | 25.64% | $192M |
| Q3 FY2025 | $1.2B | $284M | $0.70 | 20.05% | $579M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $4.7B | $836M | $2.09 | 19.56% | $1.1B |
| FY2024 | $4.0B | $576M | $1.42 | 14.88% | $631M |
| FY2023 | $3.6B | $542M | $1.30 | 16.5% | $512M |
Frequently asked questions
What was DexCom, Inc.'s revenue last quarter?
DexCom, Inc. reported revenue of $1.34 billion for Q3 FY2026, up 11.2% from the same period a year earlier.
Is DexCom, Inc. profitable?
Yes. DexCom, Inc. reported net income of $275.1 million for Q3 FY2026, a net margin of 20.46% on revenue.
How has DexCom, Inc.'s margin trended?
Operating margin was 24.34% in Q3 FY2026, compared with 20.05% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did DexCom, Inc. generate?
DexCom, Inc. generated free cash flow of $272.7 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for DexCom, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.